Edaxadiene: A New Bioactive Diterpene from Mycobacterium tuberculosis
Author(s) -
Francis M. Mann,
Meimei Xu,
Xiaohong Chen,
D. Bruce Fulton,
David G. Russell,
Reuben J. Peters
Publication year - 2009
Publication title -
journal of the american chemical society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.115
H-Index - 612
eISSN - 1520-5126
pISSN - 0002-7863
DOI - 10.1021/ja9019287
Subject(s) - diterpene , mycobacterium tuberculosis , chemistry , tuberculosis , human pathogen , metabolite , pathogen , microbiology and biotechnology , bacteria , mycobacterium , stereochemistry , biochemistry , biology , medicine , genetics , pathology , gene
Mycobacterium tuberculosis remains a widespread and devastating human pathogen. Presented here is the characterization of an atypical class I diterpene cyclase from M. tuberculosis that catalyzes an unusual cyclization reaction in converting the known M. tuberculosis metabolite halimadienyl diphosphate to a further cyclized novel diterpene, which we have termed edaxadiene, as it directly inhibits maturation of the phagosomal compartment in which the bacterium is taken up during infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom